Helpful information on the ALPHA trial is available on the links below. Please note this trial is now closed
Click each row for more information.1. Screening visit – To make sure it is safe for you to take part
To make sure you are suitable to take part, you will have some screening tests done:
If the blood test shows that it is not suitable or safe for you to take part in this study, your doctor will discuss other treatment options with you.
Depending on how your hand eczema is responding to either treatment, you may be asked to continue treatment for up to a further 12 weeks.
If, after the first 12 or 24 weeks, your randomised treatment is not helping your condition, then your doctor will stop this treatment and treat you according to local standard practice.
Here is a summary of the visits that you will need to attend whilst on the trial: